Eris Lifescience: Fy27 Revenue Growth Guidance Of 18-20%

Eris Lifescience: Fy227 Revenue Growth Guidance Of 18-20%

OLA ELECTRIC MOBILITY: Q4 EBITDA LOSS 2.8B RUPEES VS LOSS 7B (YOY)

OLA ELECTRIC MOBILITY: Q4 REVENUE 2.6B RUPEES VS 6B (YOY)

OLA ELECTRIC MOBILITY: Q4 CONS NET LOSS 5BRUPEES VS LOSS 9B (YOY)

LENSKART SOLUTIONS: Q4 EBITDA 5.4B RUPEES VS 2.9B (YOY) || Q4 EBITDA MARGIN 21.4% VS 17% (YOY)

LENSKART SOLUTIONS: Q4 REVENUE 25B RUPEES VS 17.3B (YOY)

LENSKART SOLUTIONS: Q4 CONS NET PROFIT 2B RUPEES VS 2.2B (YOY)

Shaily Engineering Plastics: Announces Approval For New Product Combining ShailyPen Neo Technology.

Grasim: Birla Opus + Birla White Putty Is Now Nearing 2 Position In The Indian Decorative Paints Industry || Birla Opus Strengthened Its Market Position 3 With An Estimated ~90 Bps QoQ Market Share Gain

Grasim: Co. Took Strategic Pricing Actions in Q4 FY26 and Q1 FY27 to Reduce Gap with Industry Competitors and Offset Increased Input Costs from Volatility.

CONTROL PRINT: Q4 EBITDA 357M RUPEES VS 303M (YOY) || Q4 EBITDA MARGIN 26.25% VS 27.14% (YOY)

CONTROL PRINT: Q4 REVENUE 1.34B RUPEES VS 1.1B (YOY)

CONTROL PRINT: Q4 SL PROFIT BEFORE TAX 321M RUPEES VS 277M (YOY) || CO HAD DEFERRED TAX GAIN 500M (YOY)

CARYSIL: Q4 REVENUE 2.34B RUPEES VS 2.04B (YOY)

CARYSIL: Q4 EBITDA 450M RUPEES VS 349M (YOY) || Q4 EBITDA MARGIN 19.3% VS 17.11% (YOY)

CARYSIL: Q4 CONS NET PROFIT 271M RUPEES VS 186M (YOY)